NAD+ IV Therapy (300 mg)

NAD+ (nicotinamide adenine dinucleotide) administered intravenously at 300 mg over 2–3 hours at Next Health Buckhead, Atlanta. NAD+ is a coenzyme central to cellular energy production and DNA repair that naturally declines with age. IV delivery achieves systemic availability not possible with oral supplements. The 300 mg dose is the standard starting point; a 750 mg higher-dose session is also available.

Next Health Atlanta Buckhead's NAD+ IV Therapy delivers nicotinamide adenine dinucleotide — a coenzyme central to cellular energy metabolism — directly into the bloodstream, bypassing the limited oral bioavailability of NAD+ precursor supplements such as NR and NMN. NAD+ serves as an electron carrier in the mitochondrial electron transport chain (complexes I and III), enabling ATP synthesis via oxidative phosphorylation; it is also consumed by PARP-1 enzymes involved in DNA repair, sirtuin longevity proteins (SIRT1–7), and cAMP signalling pathways. Plasma NAD+ levels decline progressively with age, and this decline is associated in preclinical and clinical research with impaired mitochondrial function, reduced cellular repair capacity, and hallmarks of biological ageing. The 300 mg dose at Next Health Buckhead provides a foundational NAD+ infusion and is the standard starting point for patients new to IV NAD+ therapy. The slow infusion rate — typically spread over 2–3 hours — is used because rapid NAD+ delivery can cause transient symptoms including chest tightness, nausea, and muscle cramping as the molecule is metabolised in peripheral tissues; the extended drip time allows the body to process it more comfortably. Clinical staff monitor the patient throughout the session. A 750 mg dose ($1,000) is available for patients seeking a higher systemic loading dose, commonly used when entering a more intensive longevity protocol. Regular repeat sessions — monthly or quarterly — are the approach taken by Next Health members who integrate NAD+ infusions into a sustained optimisation programme alongside other Next Health services.